Objective To investigate the keluoxin and alprostadil in the treatment of diabetic nephropathy clinical curative effect. Methods 200 patients with diabetic nephropathy were treated in our hospital from May 2014 to May, 100 patients with diabetic nephropathy were randomly divided into a control group of 50 cases, 50 cases of the observation group, cases were randomly divided into the control group, 100 cases. The control group received alprostadil treatment method, the ob-servation group received keluoxin alprostadil injection treatment method. Observe the clinical effect of the two groups and the changes of the signs. Results the total effective rate of the observation group was 94%, significantly higher than the control group, the two groups of patients with significant statistical significance(P<0.05). While the observation group of pa-tients with each clinical index were higher than the control group, the two groups of patients with significant difference (P<0.05). Conclusion in patients with diabetic nephropathy by Luo Xin combined with alprostadil in the treatment of thirst and clini-cal treatment has obvious effect, it is worth popularizing widely.%目的 观察研究渴络欣与前列地尔治疗糖尿病肾病临床治疗效果. 方法 就该院2014年5月-2015年5月收治200例糖尿病肾病患者,选取100例患者进行临床研究,随机将100例患者分为对照组50例,观察组50例. 对照组实施前列地尔治疗法,观察组实施渴络欣联合前列地尔治疗法.观察两组患者临床治疗效果及各项体征变化情况.结果观察组临床治疗总有效率为94%,明显高于对照组,两组患者对比差异有统计学意义(P<0.05).而观察组患者每项临床指标均高于对照组,两组患者对比差异有统计学意义(P<0.05). 结论 针对糖尿病肾病患者采用渴络欣联合前列地尔治疗,具有明显临床治疗效果,值得广泛推广.
展开▼
